×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in ...
Yahoo Finance
REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage...
3 days ago
Soleno Therapeutics to Participate in Upcoming Investor Conferences
FOX 2
REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage...
3 days ago
Soleno Therapeutics Shares Rise 37% After Breakthrough Designation for Diazoxide Choline
MarketWatch
By Chris Wack Soleno Therapeutics were trading near a three-year high after the Food and Drug Administration granted breakthrough therapy...
4 weeks ago
Soleno Therapeutics maintains stock target on positive outlook
Investing.com
On Thursday, Piper Sandler reiterated its Overweight rating on Soleno Therapeutics Inc. (NASDAQ:SLNO), maintaining a $93.00 price target for...
2 days ago
Soleno Therapeutics Stands with the Prader-Willi Syndrome Community
Yahoo Finance
This Prader-Willi Syndrome Awareness Day, May 15, join Soleno Therapeutics in sharing messages of hope and kindness for the Prader-Willi...
1 week ago
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
Yahoo Finance
REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq:SLNO), ("Soleno" or the "Company"),...
3 weeks ago
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Yahoo Finance
REDWOOD CITY, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical...
2 weeks ago
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
Yahoo Finance
REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq: SLNO), (“Soleno” or the “Company”),...
3 weeks ago
Wilson Sonsini Advises Soleno Therapeutics on $138 Million Public Offering
Wilson Sonsini
On May 2, 2024, Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
3 weeks ago
Soleno Therapeutics Gets Breakthrough Therapy Designation for Diazoxide Choline
Morningstar
By Chris Wack. Soleno Therapeutics said that the Food and Drug Administration has granted Breakthrough Therapy Designation for diazoxide...
4 weeks ago